Announcements Trials
Browse Landscape

Phase

Phase 1 7Phase 2 4Phase 1/2 3Phase NA 1

Status

Unknown 3Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 75Head & Neck 46Thoracic 38Breast 26Genitourinary 20Gynecologic 9Other solid neoplasm 7Sarcoma 4Dermatologic 4Other neoplasm 2Lymphoid 1

Conditions

Melanoma 4

Interventions

Nivolumab 114Ipilimumab 114pembrolizumab 108aldesleukin 76Cyclophosphamide 70fludarabine phosphate 51Interleukin-2 48Temozolomide 41Dacarbazine 36trametinib 33dabrafenib 30Bevacizumab 30sargramostim 29Radiotherapy 29incomplete Freund's adjuvant 27fludarabine 27Vemurafenib 25Radiosurgery 25Carboplatin 25Paclitaxel 23binimetinib 22Biopsy 22CTLA-4 Antigen 21Peripheral Blood Stem Cell Transplantation 20encorafenib 19cemiplimab 19atezolizumab 19Mycophenolic Acid 19HhAntag691 19Aminolevulinic Acid 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × toripalimab × Dermatologic × Clear all
NCT05031494 2025-01-06

A Study to Assess YH003 in Combination with Toripalimab(anti-PD-1 MAb) Injection in Patients with Cancers

Eucure (Beijing) Biopharma Co., Ltd

Phase 2 Completed
40 enrolled
Dermatologic

Melanoma

NCT04879654 2024-03-05

SNMM

Eye & ENT Hospital of Fudan University

Phase 2 Unknown
45 enrolled
Dermatologic

Melanoma

NCT05907512 2023-06-22

Endostar Plus Toripalimab as Adjuvant Therapy for Resectable Stage III-Oligometastatic Stage IV Cutaneous Melanoma

Fudan University

Phase 2 Unknown
43 enrolled
Dermatologic

Melanoma

NCT04884997 2021-05-13

A Study of Toripalimab or Combining With Temozolomide(iv) in the Treatment of Advanced/Metastatic Malignant Melanoma

First Affiliated Hospital of Zhejiang University

Phase 2 Unknown
90 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡